Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antipsychotic drugs metabolic abnormalities

Allison, D. B. and D. E. Casey (2001). Antipsychotic-induced weight gain a review of the literature. J Clin Psychiatry 62(Suppl 7) 22-31. Anttila, S. A. and E. V. Leinonen (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7(3) 249-64. Baptista, T., N. M. Kin, S. Beaulieu and E. A. de Baptista (2002). Obesity and related metabolic abnormalities during antipsychotic drug administration mechanisms, management and research perspectives. Pharmacopsychiatry. 35(6) 205-19. [Pg.34]

Baptista, T., N. M. Kin, S. Beaulieu and E. A. de Baptista (2002). Obesity and related metabolic abnormalities during antipsychotic drug administration mechanisms, management and research perspectives. Pharmacopsychiatry 35(6) 205-19. [Pg.130]


See other pages where Antipsychotic drugs metabolic abnormalities is mentioned: [Pg.183]    [Pg.564]    [Pg.601]    [Pg.289]    [Pg.302]    [Pg.426]    [Pg.183]    [Pg.1272]    [Pg.12]    [Pg.42]    [Pg.95]    [Pg.96]    [Pg.30]    [Pg.1223]   
See also in sourсe #XX -- [ Pg.95 ]




SEARCH



Antipsychotic drugs

Antipsychotic drugs antipsychotics

Antipsychotic drugs metabolism

Antipsychotics metabolism

Metabolism, abnormal

© 2024 chempedia.info